entertainment -WSS

entertainment

author：hotspot 2025-10-01 23:02:18 - browse：21143

The Food and Drug Administration’s advisory panel of pediatric experts met on Tuesday to discuss advances in artificial womb technology, which aim to save the lives of premature babies.

The goal of the meeting was to discuss measures for evaluating the safety and efficacy of an artificial womb. The group grappled with the limits of current animal data, as well as the ethical difficulties in running human trials. On Wednesday, the committee’s meeting will be closed to the public in order to protect trade secrets.

Extremely premature babies, defined as infants born at less than 28 weeks, rarely survive. About half of infants born at 23 weeks survive, according to a 2022 study in the Journal of the American Medical Association, and at 22 weeks just 10% survive. This population represents less than 2% of all premature babies, but the problem is growing; the Centers for Disease Control and Prevention reported that the preterm birth rate rose by 4% between 2020 and 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Chemotherapy drug shortage eases slightly but still widespread

WSS

FDA panel signals lack of confidence in Amgen cancer drug data

Readout Newsletter: Bluebird, CVS, Contineum

App could help diagnose ear infections more accurately — and at home

Creating egg and sperm cells from stem cells raises ethical issues

Chemotherapy drug shortage eases slightly but still widespread

Why Charlie Gard's case is so disturbing to Americans

focus

entertainment

entertainment

Continuity nursing helped my family in our darkest PICU moments

Colorectal cancer study finds potential in overlooked immune cell

Heart attack and stroke risk calculators need revising

Colonoscopy prep: Liquid

Drug repurposing or repositioning? The language matters

Positive childhood experiences can help future health

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Bluebird, CVS, Contineum

Continuity nursing helped my family in our darkest PICU moments

Virtual Event: March of the Biosimilars

entertainment

Chemotherapy drug shortage eases slightly but still widespread

5 to watch: Tech startups trying to solve health care's staffing crisis

A virus, fished out of a lake, may have saved a man’s life

FDA rejects Alnylam's heart disease treatment over insufficient data

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Stroke deaths set to near 10 million globally by 2050

focus

hotspot

focus

hotspot